Literature DB >> 18382996

Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre.

S A Clur1, I B Mathijssen, E Pajkrt, A Cook, R N Laurini, J Ottenkamp, C M Bilardo.   

Abstract

OBJECTIVE: To investigate the congenital heart disease (CHD) found in association with an increased nuchal translucency (NT) at 11-14 weeks of gestation in chromosomally normal and abnormal fetuses.
METHODS: Patients referred from January 1998 until May 2007 with an increased NT (> or = 95th percentile) where CHD was diagnosed were included. Chromosome analysis, fetal and postnatal echocardiography were performed. A postmortem examination followed pregnancy termination when possible.
RESULTS: Major CHD was identified in 68 of 967 fetuses with an increased NT (median NT 4.8 mm, range 2.5-22 mm). Major CHD was found in 34 of 693 fetuses (4.9%) with a normal karyotype and increased NT (median 5.2 mm, range 2.5-9.6 mm). CHD frequency increased from 1.9%, with NT between 2.5 and 3.5 mm, to 27.7% when NT was > or = 6.5 mm. Septal defects predominated (20%) when NT was < or = 3.5 mm. With NT > 3.5 mm an equal distribution of CHD types was seen. Major CHD was identified in 34 of the 274 fetuses with an abnormal karyotype and increased NT (median 4.2 mm, range 2.5-22 mm).
CONCLUSIONS: A variety of CHD is associated with an increased NT in the first trimester of pregnancy. Conotruncal defects, branchial arch derivative defects, left and right obstructive lesions (inflow and outflow) and shunts were seen. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18382996     DOI: 10.1002/pd.1985

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  Increased nuchal traslucency in normal karyotype fetuses.

Authors:  Roberta De Domenico; Marianna Faraci; Entela Hyseni; Fosca A F Di Prima; Oriana Valenti; Santo Monte; Elsa Giorgio; Eliana Renda
Journal:  J Prenat Med       Date:  2011-04

Review 2.  Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy.

Authors:  Laura Goetzl
Journal:  Clin Lab Med       Date:  2010-09       Impact factor: 1.935

3.  Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?

Authors:  Francesca Bardi; Pien Bosschieter; Joke Verheij; Attie Go; Monique Haak; Mireille Bekker; Esther Sikkel; Audrey Coumans; Eva Pajkrt; Caterina Bilardo
Journal:  Prenat Diagn       Date:  2019-11-27       Impact factor: 3.050

4.  Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening.

Authors:  Liubing Lan; Heming Wu; Lingna She; Bosen Zhang; Yanhong He; Dandan Luo; Huaxian Wang; Zhiyuan Zheng
Journal:  J Clin Lab Anal       Date:  2020-04-27       Impact factor: 2.352

5.  Increased nuchal translucency and pregnancy outcome.

Authors:  A Tahmasebpour; N Baradaran Rafiee; S Ghaffari; A Jamal
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

6.  Ultrasound and echocardiographic findings obtained in the second and third trimesters of gestation in fetuses with normal karyotype and increased nuchal translucency.

Authors:  Hanna Moczulska; Katarzyna Janiak; Maciej Słodki; Maria Respondek-Liberska
Journal:  J Ultrason       Date:  2013-03-30

7.  Prenatal and postnatal echocardiography in NT fetuses with normal karyotype.

Authors:  Abdolrahman Emami-Moghaddam; Mojgan Barati; Razie Amirpour; Kobra Shojaei
Journal:  J Family Med Prim Care       Date:  2019-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.